Multiple valve disease placement. One patient with an isolated mitral valve replacement subsequently had an aortic valve implanted, and three subsequently had a tricuspid valve implanted.
The age distribution of the patients is indicated in figure 1 , with a range from 20 to 66 years and a mean of 47 years. An additional 31 patients have undergone isolated valve replacement and concomitant valvulotomy or valvuloplasty of one or more of the remaining valves. They are not included in the above total. Fifteen per cent of the patients had previously closed mitral commissurotomy.
All patients selected for operation were functional class III or IV by the New York Heart Association Classification System. Their clinical appearance was dominated by the symptoms and physical signs of either long-standing mitral or aortic valve disease. Most of the patients had complete cardiac catheterization, and supravalvular and left ventricular angiograms. Many had selective coronary angiography in addition. A final accurate diagnosis can only be made during surgical exploration of the pathologic anatomy.
No patient has been denied surgery because of the severity of cardaic disability as determined either clinically or by hemodynamic studies. Surgery has been denied to some patients with serious associated disease such as alcoholic cirrhosis, chronic renal failure, and pulmonary fibrosis and emphysema. Ten The incidence and significance of thromboembolic complications after multiple valve replacement is shown in this pie graph.
has occurred in this multiple valve series. Figure 4 The timing of the first thromboembolus after a multiple valve replacement is demonstrated.
Circulation, Volume XXXVIII, October 1968 multiple valve replacement are shown in figure 3 . There is no apparent increase in the risk of thromboembolism with multiple replacement as compared to isolated mitral valve replacement. Figure 4 illustrates the timing of the late thromboembolic complications that have been observed. The introduction of the extended cloth prostheses (mitral #6120, and aortic #1200) in 1965 has decreased the incidence of thromboembolic complications from 61% to 7% in isolated mitral replacement, and from 29% to 9% in isolated aortic replacement. It is too early to predict accurately the embolic potential of the completely cloth-covered prostheses model #6300 mitral, and model #2300 aortic), which are now being used clinically. The necessity for long-term anticoagulant therapy is currently being evaluated in a double-blind study with these new prostheses. The majority of the patients who are unable to participate in this study are receiving routine anticoagulant therapy.
The destructive change in the silicone rubber ball, previously reported as ball variance, results from a unique and peculiar infiltration of the silicone rubber with fatty material from the blood. 4' 5 This deforms the ball and may lead to valve failure. Ball variance caused three deaths and five reoperations in multiple valve cases. Two patients had unsuspected figure  5 . Reoperation is necessary if the patient has symptoms suggesting obstruction of the aortic prosthesis or a complete absence of the prosthetic opening sound. The hollow Stellite ball of the current prostheses is designed to avoid this complication.
Functional Results
Representative cardiac catheterization findings after multiple valve replacement have been previously reported.12 14 
